Literature DB >> 12240939

Synthesis of pegylated immunonanoparticles.

Jean-Christophe Olivier1, Ramon Huertas, Hwa Jeong Lee, Frederic Calon, William M Pardridge.   

Abstract

PURPOSE: This work describes the synthesis of pegylated immunonanoparticles by conjugation of an anti-transferrin receptor monoclonal antibody (MAb) to maleimide-grafted pegylated nanoparticles prepared from poly(lactic acid) (PLA) and a bi-functional polyethyleneglycol (PEG).
METHODS: Maleimide-PEG3500-PLA40000 and methoxyPEG2600-PLA40000 copolymers were synthesized by ring opening polymerization of L-lactide using stannous octoate as catalyst. Pegylated nanoparticles were prepared from these copolymers by a multiple emulsion/solvent evaporation method and thiolated OX26 MAb was conjugated through the maleimide function located at the distal end of the PEG spacer. The pegylated immunonanoparticles were characterized by quasi-elastic light scattering, gel permeation chromatography, turbidimetry assays, and transmission electron microscopy. RESULT: NMR spectroscopy confirmed the synthesis of both copolymers and the preservation of the maleimide function. The pegylated immunonanoparticles had an average diameter of 121 +/- 5 nm and appeared spherical by transmission electron microscopy. The number of OX26 MAb molecules conjugated per individual pegylated nanoparticle was 67 +/- 4. The MAb conjugated to the surface of the pegylated immunonanoparticle was visualized directly by electron microscopy using a conjugate of 10 nm gold and an anti-mouse immunoglobulin secondary antibody.
CONCLUSION: Pegylated immunonanoparticles can be synthesized with bifunctional PEG derivatives that bridge the nanoparticle and the targeting MAb. This novel formulation may enable the targeted delivery of small molecules, protein drugs, and gene medicines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240939     DOI: 10.1023/a:1019842024814

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors:  D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.

Authors:  Y S Kang; W M Pardridge
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

3.  Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.

Authors:  C Perez; A Sanchez; D Putnam; D Ting; R Langer; M J Alonso
Journal:  J Control Release       Date:  2001-07-10       Impact factor: 9.776

4.  Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

Authors:  H Sahli; J Tapon-Bretaudière; A M Fischer; C Sternberg; G Spenlehauer; T Verrecchia; D Labarre
Journal:  Biomaterials       Date:  1997-02       Impact factor: 12.479

5.  Brain drug delivery of small molecules using immunoliposomes.

Authors:  J Huwyler; D Wu; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Transport of recombinant CD4 through the rat blood-brain barrier in vivo.

Authors:  W M Pardridge; J L Buciak; T Yoshikawa
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

7.  Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles.

Authors:  M F Zambaux; F Bonneaux; R Gref; E Dellacherie; C Vigneron
Journal:  Int J Pharm       Date:  2001-01-05       Impact factor: 5.875

8.  Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.

Authors:  P Quellec; R Gref; L Perrin; E Dellacherie; F Sommer; J M Verbavatz; M J Alonso
Journal:  J Biomed Mater Res       Date:  1998-10

9.  Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.

Authors:  W M Pardridge; R J Boado; Y S Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

Authors:  D Bazile; C Prud'homme; M T Bassoullet; M Marlard; G Spenlehauer; M Veillard
Journal:  J Pharm Sci       Date:  1995-04       Impact factor: 3.534

View more
  38 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 2.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

3.  Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.

Authors:  Ipek Baysal; Gulberk Ucar; Merve Gultekinoglu; Kezban Ulubayram; Samiye Yabanoglu-Ciftci
Journal:  J Neural Transm (Vienna)       Date:  2016-02-24       Impact factor: 3.575

Review 4.  Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Authors:  Hu Yang
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

5.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

6.  Transbuccal Delivery of CNS Therapeutic Nanoparticles: Synthesis, Characterization, and In Vitro Permeation Studies.

Authors:  Quan Yuan; Yao Fu; Weiyuan John Kao; Damir Janigro; Hu Yang
Journal:  ACS Chem Neurosci       Date:  2011-11-16       Impact factor: 4.418

Review 7.  Gold nanoparticle platforms as drug and biomacromolecule delivery systems.

Authors:  Bradley Duncan; Chaekyu Kim; Vincent M Rotello
Journal:  J Control Release       Date:  2010-06-11       Impact factor: 9.776

8.  Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells.

Authors:  Steven R Blumen; Kai Cheng; Maria E Ramos-Nino; Douglas J Taatjes; Daniel J Weiss; Christopher C Landry; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2006-10-12       Impact factor: 6.914

9.  Interaction of selegiline-loaded PLGA-b-PEG nanoparticles with beta-amyloid fibrils.

Authors:  Ipek Baysal; Samiye Yabanoglu-Ciftci; Yeliz Tunc-Sarisozen; Kezban Ulubayram; Gulberk Ucar
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

10.  Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles.

Authors:  Manoj Nahar; Narendra K Jain
Journal:  Pharm Res       Date:  2009-10-20       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.